Medical Letter On Drugs And Therapeutics

雜志介紹

Medical Letter On Drugs And Therapeutics雜志介紹

《Medical Letter On Drugs And Therapeutics》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱關(guān)于藥物和治療學的醫(yī)學信函，本刊主要出版、報道醫(yī)學-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.4，最新CiteScore 指數(shù)為1。

英文介紹

Medical Letter On Drugs And Therapeutics雜志英文介紹

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.